News about Global Pharma

American Regent Issues Voluntary Nationwide Recall of One Lot of Papaverine Hydrochloride Injection

American Regent has recalled one lot of Papaverine Hydrochloride Injection nationwide due to visible glass and paraformaldehyde particulate matter.

Global Pharma | 27/07/2026 | By News Bureau

Sanofi to not Submit Amlitelimab in Atopic Dermatitis for Global Regulatory Reviews

Sanofi will not seek global regulatory approval for amlitelimab in Atopic Dermatitis (AD) after efficacy and safety data did not support further development.

Global Pharma | 27/07/2026 | By News Bureau

US FDA Approves TYLENOL with Naproxen for OTC Use

The US Food and Drug Administration (FDA) has approved TYLENOL with Naproxen, the first OTC fixed-dose acetaminophen and naproxen combination offering up to 12 hours of pain relief.

Global Pharma | 25/07/2026 | By News Bureau |  126

Nona Biosciences Partners with Medical University of Vienna on Antibody Research

Nona Biosciences has partnered with the Medical University of Vienna to advance fully human antibody development for infectious diseases using its H2L2 Harbour Mice platform.

Global Pharma | 23/07/2026 | By News Bureau

Takeda and Indonesia Partner to Expand Access to Plasma-Derived Medicines

Takeda and Indonesia have partnered to strengthen healthcare resilience, expand access to plasma-derived medicines, and establish a national plasma donation ecosystem with an initial USD 30 million investment.

Global Pharma | 13/07/2026 | By News Bureau

Cipher Pharmaceuticals Secures pCPA Agreement to Expand Public Access to Epuris Across Canada

Cipher Pharmaceuticals has completed negotiations with the pan-Canadian Pharmaceutical Alliance, securing a Letter of Intent for Epuris (isotretinoin). The agreement represents a significant step toward expanding public drug plan coverage and improving patient access to severe acne treatment across Canada.

Global Pharma | 09/07/2026 | By News Bureau

EMA Fast-Tracks Review of New Metastatic Pancreatic Cancer Drug

The European Medicines Agency (EMA) has initiated a phased review of a new medicine for metastatic pancreatic cancer, accelerating its assessment to address a significant unmet medical need.

Global Pharma | 09/07/2026 | By News Bureau

Insilico Medicine Advances AI-Discovered IPF Drug Rentosertib into Phase III Clinical Trial

Rentosertib, formerly known as ISM001-055/INS018_055, is a potentially first-in-class oral small-molecule inhibitor targeting TNIK (TRAF2 and NCK-interacting kinase) for the treatment of IPF, a progressive and irreversible lung disease with limited treatment options.

Global Pharma | 08/07/2026 | By Abha |  242

Vertex to Acquire Crinetics Pharmaceuticals for USD 10 Billion

Under the terms of the agreement, Vertex will acquire all outstanding shares of Crinetics for USD 85 per share in cash, representing a net transaction value of approximately USD 8.8 billion after accounting for estimated cash acquired.

Global Pharma | 08/07/2026 | By Abha |  105

Ascletis Submits 2 IND Applications to the US FDA for the Treatment of Obesity

Ascletis has submitted two IND applications to the US FDA for once-monthly obesity therapies, including ASC36_35, a first-in-class triple-target candidate acting on amylin receptor, GLP-1R and GIPR.

Global Pharma | 06/07/2026 | By Akanki |  110